Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy

<table>Severity of daytime and nocturnal heartburn experienced by pregnant women at baseline and after prn treatment with Liquid Gaviscon for 4 weeks. (ITT).</table>

International Scholarly Research Notices

fig2

Figure 2

Figure 2: Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy 

Figure 2 | Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy 